Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy
- 18 August 2001
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 38 (2) , 429-435
- https://doi.org/10.1016/s0735-1097(01)01404-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Contribution of Caveolin Protein Abundance to Augmented Nitric Oxide Signaling in Conscious Dogs With Pacing-Induced Heart FailureCirculation Research, 2000
- Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE IIThe Lancet, 2000
- Comparison of ventricular pressure relaxation assessments in human heart failureJournal of the American College of Cardiology, 1999
- Pharmacokinetics of Intravenous and Oral Losartan in Patients with Heart FailureThe Journal of Clinical Pharmacology, 1998
- Increased Sensitivity to Nitric Oxide Synthase Inhibition in Patients With Heart FailureCirculation, 1998
- Single-Beat Estimation of End-Systolic Pressure-Volume Relation in HumansCirculation, 1996
- Nitric Oxide Inhibits the Positive Inotropic Response to β-Adrenergic Stimulation in Humans With Left Ventricular DysfunctionCirculation, 1995
- Clinical Experience With Angiotensin II Receptor AntagonistsAmerican Journal of Hypertension, 1992
- Effective arterial elastance as index of arterial vascular load in humans.Circulation, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991